Login

Omega Therapeutics, Inc. 8-K/A SEC Filings

Filed On Filing
30 May 2024 8-K/A: Departure/Election of Directors or Officers; Compensation

On May 28, 2024, the Company entered into an amended and restated employment agreement (the “Employment Agreement”) with Ms. Chan to serve as Senior Vice President of Finance and Chief Accounting Officer, effective as of the Effective Da...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support